M a n u s c r i p t 2 precision is between 4.5 and 8.8% while lower limits of detection between 2 and 5 34 pg/mL are below the concentrations postulated for acid-labile HCA-protein adducts in 35 blood. 36 37 38
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Introduction 43 44
Heterocyclic aromatic amines (HCAs) are formed during the cooking of proteinaceous 45 foods, particularly meat and fish, which provide creatin(in)e and other precursors such 46 as amino acids, sugars or other aldehydes [1] . Their formation in the parts per billion 47 concentration range is highly dependent upon the type of food and degree of cooking; 48 therefore making estimation of dietary exposure to HCAs difficult [2] . The past 30 years 49 have seen extensive investigation into HCAs, in terms of their production, metabolism 50
[3], formation of adducts with DNA [4] and protein [5] , their quantification [6] and 51 implications for human health. 52 53 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP), 2-amino-3,8-54 dimethylimidazo[4,5-f]quinoxaline (MeIQx) and 2-amino-3,4,8-trimethylimidazo[4,5-55 f]quinoxaline (4,8-DiMeIQx) ( Fig. 1 ) are three of the most abundant HCAs present in 56 cooked meat and fish [7, 8] although many others have been identified [9] . There is 57 strong evidence from animal and in vitro studies of the carcinogenic and mutagenic 58
properties of the HCAs although in vivo evidence correlating HCA dietary intake and 59 incidence of cancers can be equivocal [10, 11] . To overcome the limitations of 60 estimating HCA intake by food frequency questionnaires, direct measurement of the 61 HCAs, their metabolites or their DNA or protein adducts in vivo is necessary. The 62 methodology of analysis of PhIP and its metabolites has been reviewed by Teunissen 63 and colleagues [12] who concluded that LC-MS/MS was clearly the detection method of 64 choice for sensitive qualitative and quantitative analyses of this most abundant of HCAs 65 in biological matrices. Sample pretreatment for HCA analysis usually involves protein 66 precipitation, liquid-liquid extraction (LLE) or solid phase extraction (SPE) . 67 68 Hollow Fibre Membrane Liquid-Phase Microextraction (HF-LPME) techniques, which 69 employ porous membrane fibres to support an organic solvent during extraction of an 70 aqueous sample, were first introduced by Pedersen-Bjergaard and Rasmussen in 1999 71
[13] and have received considerable attention for analyses of environmental 72 contaminants and pharmaceuticals and related substances in body fluids, as reviewed 73
by Lee and colleagues [14] . More widespread adoption of HF-LPME is possible, 74 particularly in combination with LC-MS/MS detection techniques [14] . The application of A c c e p t e d M a n u s c r i p t extraction methods for HCAs (usually LLE and/or SPE) adducted to blood proteins such as serum albumin or haemoglobin) remains elusive. 86
There is a need for further validated HCA extraction techniques from blood products to 87 assist in this search. 88
89
The three-phase HF-LPME system [14] described in the current study uses a porous 90 polypropylene hollow fibre impregnated with a small volume of organic solvent (the 91 supported liquid membrane phase). An acidic aqueous acceptor phase fills the lumen of 92 the hollow fibre. The third phase is the alkaline aqueous sample (donor phase) 93 containing the weakly basic HCA analytes into which the fibre is immersed. Extraction is 94 by diffusion based on pH differences and is effectively a simultaneous double liquid-95 liquid extraction from alkaline sample to organic phase to acidic acceptor phase. 96 97 Hollow fibres require preparation by the operator prior to use. We have noted that the 98 literature employing hollow fibres for extractions from low volume biological samples 99 does not always provide clear descriptions of the procedures involved. Therefore, in the 100 current study we have focussed on some of the detailed practicalities of preparing and 101 handling hollow fibres in addition to the optimisation and validation of the extraction 102 A c c e p t e d M a n u s c r i p t 6 line filter unit (0.2 µm, 2.1 mm) (Waters Corporation), maintained at 40°C. A binary 145 gradient mobile phase was applied at a flow rate of 0.8 mL/min, phase A being 5 mM 146 ammonium formate pH 9.5 (aq) and phase B being acetonitrile. The rapid gradient 147 profile was: (1) 0-0.2 min, held at 93% A, (2) 0.2-2 min, falling linearly to 75% A, (3) 148 2.01-2.2 min, held at 70% A, (4) 2.25-2.75 min, held at 50% A, (5) 2.8-3.4 min, held at 149 93% A. The UPLC purge wash was acetonitrile:water (10:90, v/v) and the wash solution 150 was acetonitrile:water (50:50, v/v). Injection volume was 5 µl. Table 1 provides details of 151 HCA fragmentation transitions and other MS/MS conditions. 152 153
Preparation of hollow fibres 154
The optimised conditions for extraction of HCAs from plasma using HF-LPME are 155 described below. Description of the method optimisation study follows in section 2.6. 156
Porous Accurel® PP 300/1200 polypropylene hollow fibre membranes were cut into 2.5 157 cm lengths and one end was heat-sealed using a hot soldering iron -the fibre tip was 158 touched lightly onto the hot iron surface for 1-2 sec and then immediately squeezed 159 repeatedly using fine tipped metal tweezers to form a seal of approximately 3-4 mm 160 length. The fibre was cleaned by soaking in acetone for 10 min before drying at 37°C 161 for approximately 15 min (in a glass or paper container, not plastic, to avoid damage by 162 residual acetone). Sealed fibres were stored in a capped glass tube prior to use. If 163 condensation of acetone is evident during storage, fibres should be re-dried at 37°C. 164
Immediately prior to use, fibres were prepared for extraction by filling the lumen of the 165 hollow fibre with acidic acceptor phase and filling the pores of the fibre membrane with 166 organic solvent as follows. An 18 gauge hypodermic needle fitted to a 1 mL disposable 167 plastic syringe containing acidic acceptor solution (0.1 M sulphuric acid) was inserted 168 carefully into the unsealed end of the fibre ensuring the membrane was not punctured 169 and a strong seal was achieved (use of a fibre with different internal diameter would 170 require a different gauge needle). Acceptor solution was injected firmly into the lumen of 171 the fibre until droplets were clearly visible on the outer surface of the porous fibre and 172 no leakage was evident from the sealed end. The fibre was removed from the needle 173 and a clean hypodermic needle protruding through the pre-slit septum of a microvial 174 screw cap was carefully inserted. Holding the needle Luer-Lok connector, the fibre was 175 then dipped into 1-octanol for 30 sec, allowing the organic solvent to fill the membrane 176 pores. Excess 1-octanol on the fibre surface was removed by manually shaking the A c c e p t e d M a n u s c r i p t 7 immersed in a sample vial, allowing the screw cap to be sealed and the height of the 179 fibre adjusted through the pre-slit septum without removing or touching the fibre. Each 2 180 mL sample vial contained an 8 x 3 mm stirrer magnet and the needle height was 181 adjusted to avoid the stirrer damaging the sealed end of the fibre during extraction ( Fig.  182 2). phase, increasing the number of handling steps and the risk of cross-contamination. For 246 larger liquid sample volumes, a longer fibre may be used and both ends sealed before 247 complete immersion of the fibre in the sample without any support. This approach has 248 been used at the University of Seville for extraction of pharmaceuticals from urine and 249 environmental water samples [20, 21] . The use of HPLC microvials with pre-slit septa 250 screw caps as sample containers proved to be a simple way to secure the fibres and 251 needles during extraction and a convenient way to adjust fibre depth in the sample. 252
Acceptor phase could even be recovered from the fibre without removing the needle 253 from the pre-slit septum. A little practice in preparation of the fibres, particularly the 254 sealing of the ends with a soldering iron, yielded consistent results, with less than 5% of 255 fibres leaking from the sealed end when filling with acceptor phase (these fibres were 256 discarded). and AccQTag Ultra) in addition to a Phenomenex Kinetex pentafluorophenyl (PFP, 2.6 264 µm) column. All were assessed under acidic mobile phase A conditions ranging from 265 pH 3.5 to 6.4, while BEH C18 and Kinetex PFP were also assessed at alkaline pH 8.0 266 to 9.5. Notably, the BEH column yielded the best peak shape, sensitivity (peak 267 intensity) and baseline separation of the DiMeIQx isomers at pH 9.5 -the natural pH of 268 5 mM ammonium formate, avoiding the need for pH adjustment of mobile phase A (Fig.  269 3). Separation of HCAs has traditionally been achieved under acidic LC conditions 270 [1, 12] , on the principle that mobile phase pH should be lower than the analyte pKa (<pH 271 5 for the HCAs) in order to fully protonate the HCA amine groups prior to positive mode 272 electrospray ionisation. However, baseline chromatographic separation of the DiMeIQx 273 isomers is sensitive to pH and is incomplete under the commonly used pH 4.7 or lower 274 [22, 16] . Holland and colleagues [23] unusually employed a mobile phase ranging from 275 pH 6.8 to 7.85 to separate HCAs, including 4,8-DiMeIQx, in hydrolysed urine but the 276 degree of chromatographic separation from 7,8-DiMeIQx was not described. In the 277 current study, use of pH 9.5 and the UPLC gradient described above (5mM aqueous Page 10 of 28 A c c e p t e d M a n u s c r i p t min), 7,8-DiMeIQx (1.31 min), 4,8-DiMeIQx (1.38 min) and PhIP (2.21 min) with a total 280 gradient runtime of 3.4 min and typical peak widths of 3.4-3.8 sec (Fig. 4) . Ammonium 281 formate was employed as an ion pairing agent, in keeping with Bianchi and colleagues 282
[24] who demonstrated better HCA peak shapes with formate than with acetate. It may 283 be that investigators, on observing improved HCA peak shape as mobile phase pH was 284 lowered below pH 4.7, have not previously studied the benefits of LC conditions closer 285 to or higher than neutral. Nevertheless, as stated by Bianchi and colleagues [24] , 286 "depending on the specific purpose and design of the experiment, fine adjustments for 287 pH and mobile phase concentration are always recommended to achieve optimal 288 separation of HCAs". To our knowledge this is the first report of chromatographic dropping when more concentrated NaOH was used. This is in contrast to Busquets and 333 colleagues [17, 18] who suggested that PhIP or its metabolites could be extracted from 334 urine using HF-LPME with greater signal to noise ratio when mildly acidic conditions 335 were employed (pH 5.5) compared with a donor pH greater than 10. However, this 336 observation was not consistent across Busquets' studies. It is also in contradiction of 337 the conventional use of alkaline sample conditions for the extraction of a weakly basic 338 compound such as PhIP (pKa=5.6) into an organic solvent followed by back-extraction 339 into an acidic acceptor phase [15] . Furthermore, the current study shows that simply 340 raising sample pH above 10 may not be optimal for HCA extraction. Observed pH in 341 duplicate diluted plasma samples prior to extraction were as follows: 0.01 M NaOH (pH 342 11.0), 0.05 M (pH 12.5), 0.2 M (pH 13.2), 0.5 M NaOH (pH 13.5), 1 M (pH 13.6) and 2 343 M (pH 13.7). It can be seen from Fig. 5b that even at sample pH 12.5 (0.05 M NaOH), 344 extraction of HCAs may still be less than 50% of maximum. A NaOH molarity of 0.5 M A c c e p t e d M a n u s c r i p t 12 extraction from urine by HF-LPME emanating from Lund University, Sweden 348 [15, 16, 17, 18] . However, low parts per billion concentrations of PhIP and 4, were also successfully extracted from cooked meats by HF-LPME using 0.05 M NaOH 350
[19], although extraction efficiency was not described. 
Method validation 382
Solvent calibration curves were linear in the range equivalent to 5-80 pg/mL plasma 383 (10-160 pg/mL reconstitution solvent, or 50-800 fg on-column), coefficients of 384 determination R 2 typically being greater than 0.998 for all HCAs. The mean recovery 385 and precision of the HF-LPME extraction method are shown in Table 2 . Data are based 386 on 21 replicates of human plasma fortified with 30 pg/mL HCAs prior to extraction (7 387
replicates extracted on each of 3 days). Mean observed HCA concentrations (recovery) 388 were greater than 92% of fortified concentrations for all four HCAs. Precision (RSD) 389
was below 9% in all cases, both within and between runs, demonstrating satisfactory 390 performance at physiologically relevant HCA-adduct concentrations in human blood [28, 391 29] . Estimated lower limits of detection and quantification based on signal-to-noise 392 ratios greater than 3 and 10 respectively (using Peak-to-Peak calculations on 393 unsmoothed raw data) in plasma fortified with HCAs prior to extraction are shown in 394 Table 2 . Limits are based on the lowest intensity peak for each analyte. Limits for PhIP 395 are higher than for the quinoxaline HCAs due primarily to the low intensity of the 396 secondary, confirmatory transition peak for PhIP (m/z 225.2>183.2). HF-LPME assay 397 sensitivity and performance are similar to those reported by Lezamiz and colleagues 398
[15] who studied only PhIP in plasma. 399
400
Confidence in the identification of analytes is important when measuring low 401 concentrations of compounds in complex biological matrices, particularly for analyte 402 groups like the HCAs which share common structures and fragmentation patterns. The 403 presence of a second transition peak to confirm analyte identity should be a 404 prerequisite, although this is not always the case in the published literature of HCAs. 405
Furthermore, in the present study the ratio of confirmatory to primary quantitation peaks 406 (ion ratio) was monitored in every sample to ensure agreement with the same ratio in 407 calibration standards. Guidance on the tolerances to apply to compliance of ion ratios 408 with their standards was taken from the document laying out the required analytical 409 performance of methods in the veterinary pharmaceuticals field: Commission Decision 410 2002/657 [30] . While this European Commission document sets out to ensure animal-411 derived food products are free of harmful residues and is not directly applicable to the 412 study of natural carcinogens such as the HCAs, it is the opinion of the authors that 413 similar performance criteria should be applied to analysis of suspected carcinogens M a n u s c r i p t 14 2002/657 to the ion ratios in all samples: if ion ratios did not agree with the same ratios 416 in calibration standards to within 20 to 30% (dependent on the magnitude of the ratio), 417 the identity of the analyte peak could not be confirmed. Ion ratios greater than 0.5 are 418 permitted a tolerance of ±20% relative to calibration standards, 25% tolerance is 419 applied for ratios between 0.2 and 0.5, 30% for ratios of 0.1-0.2, and 50% for ratios 420 below 0.1. For example, the ratio of the peak areas of MeIQx daughter ions 131.1/199.1 421 (Table 1 ) was typically around 0.4, permitting this ratio in a sample to be within 25% of 422 the mean ratio of the same peaks in calibration standards. 423 424
Application to blood samples 425
Preliminary studies demonstrated that the HF-LPME plasma extraction method may 426 also be applied to serum and whole blood, although whole blood matrix effects caused 427 an additional 30-40% signal suppression and quantitative accuracy was adversely 428 affected, with I.S.-corrected recoveries being around 85% for the quinoxaline HCAs and 429 around 72% for PhIP (data not shown), compared with 93-99% and 92% respectively in 430 plasma ( Table 2) . 431
432
Human plasma samples were obtained from the World Cancer Research Fund project 433
FoodCAP. Samples were from volunteers whose dietary HCA intake was estimated 434
using WISP nutritional analysis software on the basis of 7 day food diaries and the US 435 National Cancer Institute's CHARRED database 436 (http://dceg.cancer.gov/tools/design/charred). Volunteers fasted for 10-12 h before 437 providing blood samples to ensure removal of free circulating HCAs from their plasma. 438
Unsurprisingly, no HCAs were detected in these samples using the optimised HF-LPME 439 extraction method, even from volunteers with a nominally high HCA intake of greater 440 than 1 µg/day. 441
442
Adducts of HCAs bound covalently to blood proteins such as haemoglobin and serum 443 albumin have, since the 1990s, been proposed as potential biomarkers of exposure to 444 HCAs (as reviewed by [2, 31] ). However, the suitability of protein adducts as reliable 445
indicators of potential carcinogenic damage by HCAs is still unproven [31] . 446
Furthermore, Magagnotti and colleagues [29] detected PhIP released by mild acid 447 hydrolysis from purified haemoglobin and serum albumin, demonstrating differences M a n u s c r i p t adducts. However, this work has not been replicated since, despite ongoing studies in 450 the field. 451
452
The current HF-LPME method was applied to plasma samples from high dietary HCA 453 intake volunteers in an attempt to measure protein-bound HCAs following their release 454 by the acid hydrolysis protocol of Magagnotti and colleagues [29] . Plasma was diluted 455 to a final concentration of 0.1 M hydrochloric acid and incubated at 80°C for 1 h before 456 adjusting the pH with NaOH and extracting by HF-LPME as described above. No acid-457 labile HCAs were detected under these conditions, demonstrating the need for further 458 work on the release of labile HCA adducts from blood proteins. A c c e p t e d M a n u s c r i p t Table 2 Validation of HCA extraction by HF-LPME from plasma fortified with 30 pg/mL HCAs (n=21; 7 replicates on 3 days). 
